Condition: Crohn Disease · Sponsor: University of Calgary
There are currently three classes of biologic treatments approved in Canada for the management of moderate-to-severe Crohn's disease: anti-tumor necrosis factor \[TNF\] alpha, anti-integrin, and anti-interleukin \[IL\]-23 targeted agents. The purpose of this trial is to determine which of these three classes of biologics results in the highest percentage of patients with small bowel (ileal) Crohn's disease entering into endoscopic remission without needing corticosteroids at 1 year. Endoscopic remission means that the ulcers in the small bowel from Crohn's disease have healed. All treatments in this trial are approved by Health Canada. No experimental drugs will be included.
This description comes directly from the study's public registry record.
Harsha Ashton · 226-919-6959 · harsha.ashton@alimentiv.com
Christopher Ma, MD MPH · 4035925013 · christopher.ma@ucalgary.ca
Always discuss trial participation with your own doctor first.
| University of Calgary | Calgary, Alberta, Canada | Recruiting |
| University of Alberta IBD Clinic | Edmonton, Alberta, Canada | Recruiting |
| GI Research Institute (G.I.R.I) | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| West Coast Gastroenterology | Vancouver, British Columbia, Canada | Not Yet Recruiting |
| Nova Scotia Health Victoria | Halifax, Nova Scotia, Canada | Active Not Recruiting |
| GNRR Digestive Clinics and Research Center Inc. | Brampton, Ontario, Canada | Not Yet Recruiting |
| Rajbir Rai Medical Corporation | Brantford, Ontario, Canada | Not Yet Recruiting |
| McMaster University | Hamilton, Ontario, Canada | Recruiting |
| London Health Sciences Centre | London, Ontario, Canada | Active Not Recruiting |
| West GTA Research Inc. | Mississauga, Ontario, Canada | Not Yet Recruiting |
| ABP Research Services Corp. | Oakville, Ontario, Canada | Not Yet Recruiting |
| Taunton Surgical Center | Oshawa, Ontario, Canada | Not Yet Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05928039